Interferon Type I
Research on interferon type i detailed by scientists at University Hospital, Department of General Internal Medicine
Published in Hepatitis Weekly, June 7th, 2010
A new study, 'Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment,' is now available. "An early virological response (EVR) after the start of interferon (IFN) treatment for chronic hepatitis C leads to a successful virological outcome. To analyze an association between sustained virological response (SVR) and EVR by comparing TaqMan with Amplicor assays in HCV genotype 1-infected patients treated with pegylated (PEG)-IFN alpha-2b plus ribavirin (RBV)," scientists writing in the journal Bmc Gastroenterology report.
"We retrospectively analyzed a total of 80...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-06-07)
More Articles from Hepatitis Weekly
- Hepatitis B Antigens
Reports summarize hepatitis b antigens study results from T. Nguyen and co-researchers - Chronic Hepatitis B Virus
New chronic hepatitis B virus study results reported from Chang Gung University, Department of Internal Medicine - Hepatitis
Data from China Agricultural University provide new insights into hepatitis - Hepatitis B Virus
Data on hepatitis B virus detailed by researchers at University of California - Hepatitis B Virus
Investigators at Austin Hospital target hepatitis B virus - Hepatitis B Virus
Investigators at Nankai University have published new data on hepatitis B virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
